Requires any amount paid on behalf of a health benefit plan enrollee to count toward the enrollee's cost-sharing
Impact
This bill is expected to have significant implications for health insurance providers, as it requires them to alter the way they calculate cost-sharing for enrollees. By integrating all payments made towards costly medications into the overall financial calculations, SB1106 seeks to promote equity in health care costs. This could benefit many patients, particularly those with chronic conditions that necessitate non-generic medications.
Summary
Senate Bill 1106 mandates that when calculating an enrollee's financial responsibility in health benefit plans, all amounts paid directly by the enrollee or on their behalf for medications without available generic substitutes must contribute toward any out-of-pocket maximums as well as any overall cost-sharing obligations. This legislation aims to ease the financial burden on individuals who must rely on non-generic medications by ensuring that their costs are recognized within their health benefit plans.
Contention
While supporters argue that SB1106 facilitates greater financial equity for individuals dependent on more expensive medications, potential critics may raise concerns about the implications for health insurance premiums. Insurers might react by raising costs to absorb the additional coverage requirements. Moreover, the bill's relationship with existing federal regulations governing health savings accounts (HSAs) may also come under scrutiny, particularly regarding how such eligibility is maintained for high deductible health plans.